Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 716
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07552558 Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBR… |
Hypofractionated Stereotactic Bod… | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Washington University School of M… | United States · Washington University School of Medic… | 2026-09-30 → 2033-11-30 | Ouvrir |
| NCT06614855 A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intr… |
C134 | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | James Markert, MD | United States · The University of Alabama at Birmingh… | 2025-06-02 → 2028-01-01 | Ouvrir |
| NCT07593092 Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanc… |
XmAb541 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Xencor, Inc. | United States · Xencor Investigative Site, Fort Worth… | 2026-06-30 → 2028-12 | Ouvrir |
| NCT07619534 Collection of CSF Samples From Participants With Metastatic Triple Nega… |
Collection of CSF Samples From Pa… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-08-18 → 2034-07-01 | Ouvrir |
| NCT03181867 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer |
18F-DCFPyL | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2017-08-03 → 2031-02-01 | Ouvrir |
| NCT00033137 Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Pre… |
Genetic Analysis of Birt Hogg-Dub… | Cancer | À vérifier | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2002-05-13 | Ouvrir |
| NCT07762703 Combination Immunotherapy Treatment for Locally Advanced Unresectable o… |
BreakVax | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | BreakBio Corp | United States · Miami Herbert Wertheim Cancer Institu… | 2026-09 → 2030-09 | Ouvrir |
| NCT06186401 Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-… |
E-SYNC T Cells | Cancer | Phase 1 | RECRUITING | En attente / non publié | Hideho Okada, MD, PhD | United States · University of California, San Francis… | 2024-04-30 → 2027-12-31 | Ouvrir |
| NCT05350475 Protons vs. Photons for High-risk Prostate Cancer |
Proton therapy | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Aarhus | Denmark · Department of Oncology, Aarhus University H… | 2022-03-01 → 2038-12-01 | Ouvrir |
| NCT07227077 Dosing Physical Activity Among Older Cancer Survivors Who Experience Ch… |
Dosing Physical Activity Among Ol… | Cancer | Non applicable | RECRUITING | En attente / non publié | Medical College of Wisconsin | United States · Froedtert Hospital, Milwaukee, United… | 2026-02-07 → 2027-08 | Ouvrir |
| NCT05873699 Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopi… |
Hyperpolarized 13-C-pyruvate | Cancer | Phase 1 | SUSPENDED | En attente / non publié | M.D. Anderson Cancer Center | United States · M D Anderson Cancer Center, Houston, … | 2023-08-18 → 2027-01-31 | Ouvrir |
| NCT04692675 Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Di… |
Multiparametric Magnetic Resonanc… | Cancer | Non applicable | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2022-11-18 → 2031-09-01 | Ouvrir |
| NCT07488624 Survival Prediction After Neoadjuvant Chemoimmunotherapy and Esophagect… |
Survival Prediction After Neoadju… | Cancer | À vérifier | COMPLETED | En attente / non publié | Sichuan University | China · Mianzhu People's Hospital (West China Mianzhu… | 2026-03-01 → 2026-06-01 | Ouvrir |
| NCT05276726 A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C a… |
JAB 21822 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Allist Pharmaceuticals, Inc. | China · Research site01, Beijing, China | Research si… | 2022-08-17 → 2027-08 | Ouvrir |
| NCT07763184 mNGS for IFD in Patients With Hematological Malignancies |
mNGS for IFD in Patients With Hem… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Nanfang Hospital, Southern Medica… | China · Nanfang Hospital, Southern Medical University… | 2026-08-10 → 2027-12-31 | Ouvrir |
| NCT01267955 Vismodegib in Treating Patients With Advanced Chondrosarcomas |
Vismodegib | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | France · Centre Leon Berard, Lyon, France | Centre Os… | 2010-12-21 → 2027-07-21 | Ouvrir |
| NCT06703216 PACER — Pre-emptive Anakinra for Cytokine Event Reduction |
Anakinra (Kineret®) | Cancer | Phase 1 | WITHDRAWN | En attente / non publié | Kevin McNerney | United States · Ann & Robert H. Lurie Children's Hosp… | 2026-10 → 2030-02-28 | Ouvrir |
| NCT01784068 ENESTfreedom — Nilotinib Treatment-free Remission Study in CML (Chronic… |
Nilotinib followed by treatment-f… | Cancer | Phase 2 | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Austria, Belgium, Bulgaria,… | 2013-03-19 → 2025-01-23 | Ouvrir |
| NCT07147231 Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461),… |
Biopsy Procedure | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Emory Saint Joseph's Hospital, Atlant… | 2026-08-10 → 2027-09-30 | Ouvrir |
| NCT06956001 Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatmen… |
Firmonertinib Mesilate Tablets | Cancer | Phase 3 | RECRUITING | En attente / non publié | Allist Pharmaceuticals, Inc. | China · Ethics Committee of cancer hospital, Chinese … | 2024-11-19 → 2028-07 | Ouvrir |
| NCT03409432 Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB… |
Brentuximab Vedotin | Cancer | Phase 2 | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · Ohio State University Comprehensive C… | 2018-03-16 → 2025-07-16 | Ouvrir |
| NCT07696715 TIME-NL — Timing of Immunotherapy in Melanoma |
TIME-NL — Timing of Immunotherapy… | Cancer | Non applicable | RECRUITING | En attente / non publié | Radboud University Medical Center | Netherlands · Amsterdam UMC, Amsterdam, Netherlands |… | 2026-08-10 → 2033-09-30 | Ouvrir |
| NCT07761988 The FamilyStrong Pilot Randomized Trial |
The FamilyStrong Pilot Randomized… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Alabama at Birmingh… | United States · University of Alabama at Birmingham, … | 2027-01-01 → 2028-09-30 | Ouvrir |
| NCT07716579 Assessment of Endocrine and Metabolic Late Effects After Childhood Brai… |
Assessment of Endocrine and Metab… | Cancer | Non applicable | COMPLETED | En attente / non publié | Institute of Oncology Ljubljana | Slovenia · Institute of Oncology Ljubljana, Ljubljana… | 2023-07-03 → 2025-12-31 | Ouvrir |
| NCT07391774 Testing Whether Hormone Therapy With Ribociclib is as Effective as Chem… |
Anastrozole | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Puerto Rico · Abbott-Northwestern Hosp… | 2026-08-10 → 2029-07-31 | Ouvrir |